Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6697762 | 1.00 | CYP1A2 (0.34) | CYP1A2ALDH1A1ACHECHRM5ADRA2C | |
| SCHEMBL6692863 | 0.98 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL6690577 | 0.93 | — | — | |
| SCHEMBL6690880 | 0.87 | — | — | |
| SCHEMBL721766 | 0.83 | CYP1A2 (0.36) | CYP1A2ALDH1A1ACHECHRM5ADRA2C | |
| SCHEMBL6692807 | 0.83 | CYP1A2 (0.36) | CYP1A2ALDH1A1ACHECHRM5ADRA2C | |
| SCHEMBL17750053 | 0.81 | CYP1A2 (0.34) | CYP1A2ALDH1A1ACHECHRM5ADRA2C | |
| SCHEMBL6691821 | 0.80 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL7643953 | 0.78 | CYP1A2 (0.36) | CYP1A2ALDH1A1ACHECHRM5ADRA2C | |
| SCHEMBL7445835 | 0.78 | CYP1A2 (0.36) | CYP1A2ALDH1A1ACHECHRM5ADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2004523599-A | — | — | 2004-08-05 | — | — | JP | claimed |
| EP-1353961-A2 | (CYCLOALKYL)METHYL SILANES AS EXTERNAL DONORS FOR POLYOLEFIN CATALYSTS | ENGELHARD CORPORATION (US) | 2003-10-22 | — | — | EP | claimed |
| US-6469112-B2 | SOLID TITANIUM CATALYST COMPONENT; AN ORGANOALUMINUM COMPOUND; AND AN ORGANOSILICON COMPOUND COMPRISING AT LEAST ONE (CYCLOALKYL)METHYL GROUP; MAKING HIGH XYLENE SOLUBLE POLYOLEFINS WITH CATALYTIC EFFICIENCY | ENGELHARD CORPORATION | 2002-10-22 | — | — | US | claimed |
| US-20020028893-A1 | (Cycloalkyl) methyl silanes as external donors for polyolefin catalysts | W. R. GRACE & CO.-CONN. | 2002-03-07 | — | — | US | claimed |
| WO-2002016444-A2 | (CYCLOAKYL)METHYL SILANES AS EXTERNAL DONORS FOR POLYOLEFIN CATALYSTS | ENGELHARD CORPORATION (US) | 2002-02-28 | — | — | WO | claimed |
| US-12559632-B2 | Weather-resistant, fungal-resistant, and stain-resistant coatings and methods of applying on wood, masonry, or other porous materials | UNIVERSITY OF HOUSTON SYSTEM (US) | 2026-02-24 | — | — | US | disclosed |
| US-12312534-B2 | Treating fluid comprising hydrocarbons, water, and polymer | CHEVRON U.S.A. INC. (US) | 2025-05-27 | — | — | US | disclosed |
| US-20240067865-A1 | TREATING FLUID COMPRISING HYDROCARBONS, WATER, AND POLYMER | CHEVRON U.S.A. INC. | 2024-02-29 | — | — | US | disclosed |
| US-11834606-B2 | Treating fluid comprising hydrocarbons, water, and polymer | CHEVRON U.S.A. INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230323193-A1 | PH CONTROL IN FLUID TREATMENT | CHEVRON U.S.A. INC. | 2023-10-12 | — | — | US | disclosed |
| CN-116023549-A | Prepolymerized catalyst, preparation method and application thereof | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| US-11591893-B2 | PH control in fluid treatment | CHEVRON U.S.A. INC. (US) | 2023-02-28 | — | — | US | disclosed |
| EP-1353961-A2 | (CYCLOALKYL)METHYL SILANES AS EXTERNAL DONORS FOR POLYOLEFIN CATALYSTS | ENGELHARD CORPORATION (US) | 2003-10-22 | — | — | EP | disclosed |
| US-6469112-B2 | SOLID TITANIUM CATALYST COMPONENT; AN ORGANOALUMINUM COMPOUND; AND AN ORGANOSILICON COMPOUND COMPRISING AT LEAST ONE (CYCLOALKYL)METHYL GROUP; MAKING HIGH XYLENE SOLUBLE POLYOLEFINS WITH CATALYTIC EFFICIENCY | ENGELHARD CORPORATION | 2002-10-22 | — | — | US | disclosed |
| US-20020028893-A1 | (Cycloalkyl) methyl silanes as external donors for polyolefin catalysts | W. R. GRACE & CO.-CONN. | 2002-03-07 | — | — | US | disclosed |
| WO-2002016444-A2 | (CYCLOAKYL)METHYL SILANES AS EXTERNAL DONORS FOR POLYOLEFIN CATALYSTS | ENGELHARD CORPORATION (US) | 2002-02-28 | — | — | WO | disclosed |
| US-6191232-B1 | A PROPYLENE BLOCK COPOLYMER PRODUCED BY CONTINUOUS POLYMERIZATION COMPRISING POLYMER PARTICLES, HAVING RUBBER COMPONENT OF AN ALPHA-OLEFIN HAVING 2 TO 18 CARBON ATOMS; EXCELLENT IN RIGIDITY AND IMPACT RESISTANCE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-02-20 | — | — | US | disclosed |
| US-5859143-A | BLOCK COPOLYMERIZATION REACTION IN PRESENCE OF HYDROGEN AND STEREOSPECIFIC CATALYST CONTAINING COMPOUNDS OF MAGNESIUM, TITANIUM, HALOGEN, ORGANOALUMINUM AND ELECTRON DONOR | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-01-12 | — | — | US | disclosed |
| CN-1027643-C | Catalyst component and catalyst for olefin polymerization | HIMONT INC (US) | 1995-02-15 | — | — | CN | disclosed |
| CN-1053241-A | The catalyst component of olefinic polymerization and catalyzer | HIMONT INC (US) | 1991-07-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559632-B2 | Weather-resistant, fungal-resistant, and stain-resistant coatings and methods of applying on wood, masonry, or other porous materials | GMDS, MGAM, STS | CYP1A2 1610/4885ALDH1A1 4200/4885ACHE 3969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.